June 6 - July 18
ADDF-HARRINGTON SCHOLAR AWARD
Harrington Discovery Institute and the Alzheimer’s Drug Discovery Foundation (ADDF) invite you to submit a letter of intent (LOI) for the 2022 ADDF-Harrington Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to neurovascular health and epigenetics. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are encouraged to apply. In addition to grant funding, Harrington Discovery Institute provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.
PhD or MD or equivalent required for eligibility. Open to researchers in the U.S., U.K. and Canada.
Letters of Intent (LOI) Submission Deadline: July 18, 2022
To submit an online application, go to ADDF’s grant system and create an account.
To learn more about the ADDF-Harrington Scholar program, click here.
For more information, contact Fedor Kossakovski.